The Global Partnership for Zero Leprosy (GPZL) is excited to announce a new capacity-building pilot program. This initiative is specifically designed to strengthen and support associations led by persons affected by leprosy that are small, new, or have historically had limited access to structured external … Read More >
By Dr Ritu Ghosh, Executive Director, GPZL I remember a conversation with a community member during a field visit a few years ago. We were reviewing what, on paper, looked like a well-designed health intervention. Coverage was improving. Indicators were moving in the right direction. … Read More >
We sincerely appreciate the Leeds Disability Studies Centre at the University of Leeds for their thoughtful consideration in including persons affected by leprosy for a scholarship opportunity under the online MSc in Disability Studies, Rights and Inclusion programme. This reflects a meaningful commitment to advancing … Read More >
World Leprosy Day 2026 Theme: Leprosy (Hansen’s disease) is curable. The real challenge is stigma. At GPZL, people with lived experience of leprosy (Hansen’s disease) are at the centre of everything we do. Hear directly from members of our Prioritising People Pillar Group as they … Read More >
Are you working in leprosy management, logistics, or health service delivery? We want to hear from you. The Global Partnership for Zero Leprosy (GPZL) is launching a global survey to map the “last-mile” challenges and successes in delivering multidrug therapy (MDT) to every person who … Read More >
The World Health Organization (WHO) has launched the Global Report on Neglected Tropical Diseases 2025, marking 20 years of global action and data against some of the world’s most persistent yet preventable diseases. The report highlights major milestones achieved through collective effort — from the … Read More >
The ongoing International Leprosy Congress (#ILC2025) has provided a strategic platform for the Global Partnership for Zero Leprosy (GPZL) to reaffirm its leadership in the global quest to eliminate leprosy. More than just participating, GPZL has actively engaged stakeholders, shared critical insights, and demonstrated the … Read More >
The Global Partnership for Zero Leprosy (GPZL) is excited to announce its participation at the 2025 International Leprosy Congress (ILC) and the hosting of its Members’ Assembly Meeting, both taking place in Bali, Indonesia. The ILC will run from 7–9 July 2025, followed by the … Read More >
The Global Partnership for Zero Leprosy (GPZL) is proud to announce the election of two new Representatives of National Leprosy Programmes to its Members’ Assembly (Global Board): Dr. Munirah Abdullahi Onimisi from Nigeria and Dr. Rabindra Baskota from Nepal. Their election reflects the GPZL’s commitment … Read More >
Kathmandu | 8–9 May 2025 Nepal is demonstrating bold political leadership in the fight against leprosy. Our Executive Director, Dr. Ritu Ghosh is attending the Nepal Leprosy Conference, a pivotal high-level event aimed at accelerating national efforts toward a leprosy-free Nepal. She is participating as … Read More >
We are pleased to announce that Ritu Ghosh, Executive Director of the Global Partnership for Zero Leprosy (GPZL), will be a panellist at the upcoming event “Leprosy in India: Down but Not Out. What Are We Doing About It?” The event, , will take place … Read More >
Call for submissions on the draft of general comment No. 27 on children’s right to access to justice and to an effective remedy
We are delighted to welcome Mr. Vickash Chetry to the GPZL team as our new Officer – Finance, Administration, and Human Resources. We are confident that his expertise and dedication will be a valuable addition to our team as we continue working towards our shared goals.
The Global Partnership for Zero Leprosy (GPZL) is seeking nominations for Representatives of National Leprosy Programs to serve on its Members’ Assembly for a two-year term, renewable once. The term will begin on 1 April 2025.
With the support of GPZL partner organizations, the consultant will conduct a comprehensive assessment of MDT, Clofazimine, Prednisolone, and Rifampicin supply chain challenges in the selected countries, identifying inefficiencies, key barriers, and opportunities for improvement.
Interview with Mr. Amar Timalsina, Chair of the GPZL – Prioritizing People Pillar Group.
End Stigma and Discrimination against Persons Affected by Leprosy On January 30, 2025, Bhubaneswar, capital of India’s Odisha state, hosts the launch of Global Appeal 2025 to End Stigma and Discrimination against Persons Affected by Leprosy. This is the 20th Global Appeal since the first was … Read More >
The theme for World Leprosy Day 2025 is “Unite. Act. Eliminate.”. The theme is a call to action aiming to raise awareness of leprosy, highlight the challenges faced by persons affected by leprosy, and inspire collaborative action to eliminate leprosy.
Many people affected by leprosy (Hansen’s disease) are being denied timely access to life-saving treatment due to logistical failures and funding shortfalls, the UN experts warned today.
Hansen’s disease, also known as leprosy, is not just a medical condition – it affects every aspect of a person’s life. It impacts independence, mobility, and is often linked to deformity, which in turn leads to severe social stigma and discrimination. This stigma creates barriers … Read More >